Literature DB >> 20212083

The evolution of cancer modeling: the shadow of stem cells.

Carolina Vicente-Dueñas1, César Cobaleda, Jesús Pérez-Losada, Isidro Sánchez-García.   

Abstract

Cancer is a complex and highly dynamic process. Genetically engineered mouse models (GEMs) that develop cancer are essential systems for dissecting the processes that lead to human cancer. These animal models provide a means to determine the causes of malignancy and to develop new treatments, thus representing a resource of immense potential for medical oncology. The sophistication of modeling cancer in mice has increased to the extent that now we can induce, study and manipulate the cancer disease process in a manner that is impossible to perform in human patients. However, all GEMs described so far have diverse shortcomings in mimicking the hierarchical structure of human cancer tissues. In recent years, a more detailed picture of the cellular and molecular mechanisms determining the formation of cancer has emerged. This Commentary addresses new experimental approaches toward a better understanding of carcinogenesis and discusses the impact of new animal models.

Entities:  

Mesh:

Year:  2010        PMID: 20212083      PMCID: PMC2869490          DOI: 10.1242/dmm.002774

Source DB:  PubMed          Journal:  Dis Model Mech        ISSN: 1754-8403            Impact factor:   5.758


  45 in total

Review 1.  The case for early detection.

Authors:  Ruth Etzioni; Nicole Urban; Scott Ramsey; Martin McIntosh; Stephen Schwartz; Brian Reid; Jerald Radich; Garnet Anderson; Leland Hartwell
Journal:  Nat Rev Cancer       Date:  2003-04       Impact factor: 60.716

2.  Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML.

Authors:  Catriona H M Jamieson; Laurie E Ailles; Scott J Dylla; Manja Muijtjens; Carol Jones; James L Zehnder; Jason Gotlib; Kevin Li; Markus G Manz; Armand Keating; Charles L Sawyers; Irving L Weissman
Journal:  N Engl J Med       Date:  2004-08-12       Impact factor: 91.245

3.  Somatic activation of the K-ras oncogene causes early onset lung cancer in mice.

Authors:  L Johnson; K Mercer; D Greenbaum; R T Bronson; D Crowley; D A Tuveson; T Jacks
Journal:  Nature       Date:  2001-04-26       Impact factor: 49.962

4.  Reversibility of acute B-cell leukaemia induced by BCR-ABL1.

Authors:  C S Huettner; P Zhang; R A Van Etten; D G Tenen
Journal:  Nat Genet       Date:  2000-01       Impact factor: 38.330

5.  Prospective identification of tumorigenic breast cancer cells.

Authors:  Muhammad Al-Hajj; Max S Wicha; Adalberto Benito-Hernandez; Sean J Morrison; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

Review 6.  Stem cells, cancer, and cancer stem cells.

Authors:  T Reya; S J Morrison; M F Clarke; I L Weissman
Journal:  Nature       Date:  2001-11-01       Impact factor: 49.962

7.  Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice.

Authors:  Paul J Grippo; Patrick S Nowlin; Michael J Demeure; Daniel S Longnecker; Eric P Sandgren
Journal:  Cancer Res       Date:  2003-05-01       Impact factor: 12.701

8.  Engineering de novo reciprocal chromosomal translocations associated with Mll to replicate primary events of human cancer.

Authors:  Alan Forster; Richard Pannell; Lesley F Drynan; Matthew McCormack; Emma C Collins; Angelika Daser; Terence H Rabbitts
Journal:  Cancer Cell       Date:  2003-05       Impact factor: 31.743

9.  SLUG (SNAI2) deletions in patients with Waardenburg disease.

Authors:  Manuel Sánchez-Martín; Arancha Rodríguez-García; Jesús Pérez-Losada; Ana Sagrera; Andrew P Read; Isidro Sánchez-García
Journal:  Hum Mol Genet       Date:  2002-12-01       Impact factor: 6.150

10.  A luminal epithelial stem cell that is a cell of origin for prostate cancer.

Authors:  Xi Wang; Marianna Kruithof-de Julio; Kyriakos D Economides; David Walker; Hailong Yu; M Vivienne Halili; Ya-Ping Hu; Sandy M Price; Cory Abate-Shen; Michael M Shen
Journal:  Nature       Date:  2009-09-09       Impact factor: 49.962

View more
  4 in total

1.  MALT lymphoma meets stem cells.

Authors:  Carolina Vicente-Dueñas; César Cobaleda; José Ángel Martínez-Climent; Isidro Sánchez-García
Journal:  Cell Cycle       Date:  2012-07-24       Impact factor: 4.534

2.  The cellular architecture of multiple myeloma.

Authors:  Carolina Vicente-Dueñas; Isabel Romero-Camarero; Francisco Javier García-Criado; César Cobaleda; Isidro Sánchez-García
Journal:  Cell Cycle       Date:  2012-09-14       Impact factor: 4.534

3.  TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality.

Authors:  Jue Wang; Tongjuan Li; Mi Zhou; Zheng Hu; Xiaoxi Zhou; Shiqiu Zhou; Na Wang; Liang Huang; Lei Zhao; Yang Cao; Min Xiao; Ding Ma; Pengfei Zhou; Zhen Shang; Jianfeng Zhou
Journal:  Sci Rep       Date:  2015-12-16       Impact factor: 4.379

4.  AXL induces epithelial-to-mesenchymal transition and regulates the function of breast cancer stem cells.

Authors:  M K Asiedu; F D Beauchamp-Perez; J N Ingle; M D Behrens; D C Radisky; K L Knutson
Journal:  Oncogene       Date:  2013-03-11       Impact factor: 9.867

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.